Oct 23, 2014 7:30am EDT Sutro Biopharma and Celgene Corporation Enter Multi-Year Strategic Collaboration and Option to Acquire Agreement
Sep 22, 2014 8:00am EDT FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014
Sep 17, 2014 8:00am EDT Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates
Sep 09, 2014 9:00am EDT Sutro Biopharma to Collaborate with University of California, San Francisco (UCSF), a Recombinant Antibody Network (RAN) Member
Mar 24, 2014 9:00am EDT Sutro Biopharma to Present at 21st Annual Future Leaders in the Biotech Industry Conference
Jan 07, 2014 9:00am EST Sutro Biopharma to Collaborate With Memorial Sloan-Kettering Cancer Center to Produce Bispecific Antibodies for the Treatment of Neuroblastoma
Dec 11, 2013 9:00am EST Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
Oct 15, 2013 2:00pm EDT Sutro Biopharma Presents Dual-Warhead Antibody Drug Conjugate at the World ADC Summit
Jan 03, 2013 9:00am EST Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates
